Detalles de la búsqueda
1.
Role of SH3GLB1 in the regulation of CD133 expression in GBM cells.
BMC Cancer
; 23(1): 713, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525108
2.
SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer.
Int J Mol Sci
; 22(20)2021 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681918
3.
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets.
J Biomed Sci
; 26(1): 77, 2019 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31629402
4.
A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Gastroenterology
; 145(5): 1110-20, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23896173
5.
CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.
Cell Death Dis
; 15(6): 434, 2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38898023
6.
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.
J Exp Clin Cancer Res
; 41(1): 220, 2022 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35831908
7.
Correction: Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells.
J Exp Med
; 220(7)2023 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339062
8.
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells.
J Exp Med
; 213(13): 2967-2988, 2016 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27881732
Resultados
1 -
8
de 8
1
Próxima >
>>